Note this event requires pre-registration :  

Pre-registration has ended. You may still attend as a walk-in (if space permit).
Pay at the door $25 in cash or check only.

Rani Therapeutics: Converting biologic drugs into pills!

Mir Imran, CEO Rani Therapeutics/InCube Laboratories

Over a hundred attempts have been made in the last 50 years to deliver biologics orally, and most have failed. Rani Therapeutics has developed a “robotic” pill that has demonstrated (in preclinical studies) bioavailability equivalent to a subcutaneous injection for several biologic drugs. Mir will discuss the RaniPillTM technology, some preclinical data and the financing history of the company. .

 

Mir Imran is a prolific healthcare innovator and entrepreneur who has been developing and commercializing breakthrough medical innovations for more than 40 years. Since 1995, Mir’s innovations have been developed at his life science R&D lab and incubator, InCube Labs. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen “liquidity events” (IPO/Acquisition). Mir now holds more than 400 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator.  Mir has received a number of industry accolades for his work including being named one of the most inspiring people in life sciences (PharmaVoice) and one of the “Top 50 Medical Device Inventors of All Time” (QMed). Mir has also been recognized as a fellow for both the National Academy of Inventors (NAI) and the National Academy of Engineering (NAE). He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. Mir also attended CMDNJ/Rutgers Medical School.

Event Information

Event Topic:
Rani Therapeutics: Converting biologic drugs into pills!

Event Description:
Over a hundred attempts have been made in the last 50 years to deliver biologics orally, and most have failed. Rani Therapeutics has developed a “robotic” pill that has demonstrated (in preclinical studies) bioavailability equivalent to a subcutaneous injection for several biologic drugs. Mir will discuss the RaniPillTM technology, some preclinical data and the financing history of the company.

Date/Time:
Date(s) - 06/11/19
6:00 pm - 9:00 pm

Event Location:
Wilson Sonsini Goodrich & Rosati – 650 Page Mill Rd, Palo Alto:

Speaker Information

Event Speaker:
Mir Imran

Event Speaker Title:
CEO

Event Speaker Company:
Rani Therapeutics and InCube Labs

Event Speaker Bio:

Mir Imran is a prolific healthcare innovator and entrepreneur who has been developing and commercializing breakthrough medical innovations for more than 40 years. Since 1995, Mir’s innovations have been developed at his life science R&D lab and incubator, InCube Labs. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen “liquidity events” (IPO/Acquisition). Mir now holds more than 400 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. Mir has received a number of industry accolades for his work including being named one of the most inspiring people in life sciences (PharmaVoice) and one of the “Top 50 Medical Device Inventors of All Time” (QMed). Mir has also been recognized as a fellow for both the National Academy of Inventors (NAI) and the National Academy of Engineering (NAE). He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. Mir also attended CMDNJ/Rutgers Medical School.

Event Details

Cost:
Members $11 who pre-registered; $6- Student/In-transition; General Public $20, Walk-In, $25 (if space permits)

Add To Calendar